Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjay Rastogi

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
American Journal of Nephrology|July 20, 2016
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis PatientsStuart M Sprague, Adrian C Covic, Jürgen Floege, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|April 30, 2019
Primary membranous nephropathy with concomitant IgA nephropathyReza Khorsan, Ramy M Hanna, Khalid Ameen, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|May 13, 2020
A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosisMichael Shye, Anthony Sisk, Carl Schulze, et al.
Therapeutics and Clinical Risk Management|November 7, 2019
Autosomal dominant polycystic kidney disease: updated perspectivesAnjay Rastogi, Khalid Mohammed Ameen, Maha Al-Baghdadi, et al.
Clinical Case Reports|March 28, 2022
Acute interstitial nephritis observed with three different triggering agentsNiloofar Nobakht, Ramy M Hanna, Mohammad Kamgar, et al.
SAGE Open Medical Case Reports|August 27, 2019
Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapyRamy M Hanna, Farid Arman, Umut Selamet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2018
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patientsMarkus Ketteler, Stuart M Sprague, Adrian C Covic, et al.
Kidney Medicine|August 1, 2020
Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical ReviewNiloofar Nobakht, Ramy M Hanna, Maha Al-Baghdadi, et al.
Journal of Primary Care & Community Health|August 15, 2024
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by NephrologistsAnjay Rastogi, Ashté Collins, Ellie Kelepouris, et al.
Advances in Kidney Disease and Health|November 22, 2024
Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US NephrologistsAnjay Rastogi, Glenn M Chertow, Ashté Collins, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
American Journal of Nephrology|July 20, 2016
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis PatientsStuart M Sprague, Adrian C Covic, Jürgen Floege, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|April 30, 2019
Primary membranous nephropathy with concomitant IgA nephropathyReza Khorsan, Ramy M Hanna, Khalid Ameen, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|May 13, 2020
A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosisMichael Shye, Anthony Sisk, Carl Schulze, et al.
Therapeutics and Clinical Risk Management|November 7, 2019
Autosomal dominant polycystic kidney disease: updated perspectivesAnjay Rastogi, Khalid Mohammed Ameen, Maha Al-Baghdadi, et al.
Clinical Case Reports|March 28, 2022
Acute interstitial nephritis observed with three different triggering agentsNiloofar Nobakht, Ramy M Hanna, Mohammad Kamgar, et al.
SAGE Open Medical Case Reports|August 27, 2019
Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapyRamy M Hanna, Farid Arman, Umut Selamet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2018
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patientsMarkus Ketteler, Stuart M Sprague, Adrian C Covic, et al.
Kidney Medicine|August 1, 2020
Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical ReviewNiloofar Nobakht, Ramy M Hanna, Maha Al-Baghdadi, et al.
Journal of Primary Care & Community Health|August 15, 2024
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by NephrologistsAnjay Rastogi, Ashté Collins, Ellie Kelepouris, et al.
Advances in Kidney Disease and Health|November 22, 2024
Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US NephrologistsAnjay Rastogi, Glenn M Chertow, Ashté Collins, et al.
Pageof 10